ReviewHandbook of experimental pharmacology2013
Sphingolipids in obesity, type 2 diabetes, and metabolic disease.
S B Russo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
61 papers cite itlatest 60 shown
this paperpooled itcites it